÷´Ü ¾à¹°Àü´Þ ½Ã½ºÅÛ : ¼¼°è ½ÃÀå°ú ±â¼ú
Global Markets and Technologies for Advanced Drug Delivery Systems
»óǰÄÚµå : 1423537
¸®¼­Ä¡»ç : BCC Research
¹ßÇàÀÏ : 2024³â 02¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 265 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,650 £Ü 6,455,000
PDF & Excel (Single User License) help
PDF ¹× Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,580 £Ü 7,746,000
PDF & Excel (2-5 Users) help
PDF ¹× Excel º¸°í¼­¸¦ 2-5¸íÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,696 £Ü 9,296,000
PDF & Excel (Site License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,035 £Ü 11,154,000
PDF & Excel (Enterprise License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°è ÷´Ü ¾à¹°Àü´Þ ½Ã½ºÅÛ ½ÃÀå ±Ô¸ð´Â 2023³â 2,626¾ï ´Þ·¯¿¡¼­ ¿¹Ãø ±â°£ µ¿¾È 6.5%ÀÇ CAGRÀ» ±â·ÏÇϸç 2028³â ¸»¿¡´Â 3,591¾ï ´Þ·¯ ±Ô¸ð·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ºÏ¹Ì ½ÃÀåÀº 2023³â 1,094¾ï ´Þ·¯¿¡¼­ ¿¬Æò±Õ 6.8% ¼ºÀåÇÏ¿© 2028³â ¸»¿¡´Â 1,521¾ï ´Þ·¯ ±Ô¸ð·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀåÀº 2023³â 477¾ï ´Þ·¯¿¡¼­ ¿¬Æò±Õ 7.5% ¼ºÀåÇØ 2028³â ¸»¿¡´Â 686¾ï ´Þ·¯ ±Ô¸ð·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼¼°è ÷´Ü ¾à¹°Àü´Þ ½Ã½ºÅÛ ½ÃÀåÀ» Á¶»çÇßÀ¸¸ç, ½ÃÀå °³¿ä, ½ÃÀå ¿µÇâ¿äÀÎ ¹× ½ÃÀå ±âȸ ºÐ¼®, ½ÃÀå ±Ô¸ð ÃßÀÌ ¹× ¿¹Ãø, °¢ ºÎ¹®º°¡¤Áö¿ªº° »ó¼¼ ºÐ¼®, ÀÓ»ó½ÃÇè ¹× Æ¯Çã µ¿Çâ, °æÀï »óȲ, ÁÖ¿ä ±â¾÷ °³¿ä µîÀÇ Á¤º¸¸¦ Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ¿ä¾à°ú ÇÏÀ̶óÀÌÆ®

Á¦3Àå ½ÃÀå °³¿ä

Á¦4Àå ½ÃÀå ¿ªÇÐ

Á¦5Àå ½ÃÀå Æò°¡ : ±â¼úº°

Á¦6Àå ½ÃÀå Æò°¡ : Åõ¿© °æ·Îº°

Á¦7Àå ½ÃÀå Æò°¡ : ºñÈ÷Ŭ/ij¸®¾îº°

Á¦8Àå ½ÃÀå Æò°¡ : ¿ëµµº°

Á¦9Àå ½ÃÀå Æò°¡ : Áö¿ªº°

Á¦10Àå ESG Àü°³

Á¦11Àå ½ÃÀåÀÇ ½Å±â¼ú

Á¦12Àå ÀÓ»ó½ÃÇ衤ƯÇ㠺м®

Á¦13Àå °æÀï Á¤º¸

Á¦14Àå ±â¾÷ °³¿ä

Á¦15Àå ºÎ·Ï : µÎ¹®ÀÚ¾î

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Highlights:

The global market for advanced drug delivery systems is expected to increase from $262.6 billion in 2023 to $359.1 billion by the end of 2028, with a compound annual growth rate (CAGR) of 6.5% during the forecast period of 2023-2028.

North American market for advanced drug delivery systems is expected to increase from $109.4 billion in 2023 to $152.1 billion by the end of 2028, with a CAGR of 6.8% during the forecast period of 2023-2028.

Asia-Pacific market for advanced drug delivery systems is expected to increase from $47.7 billion in 2023 to $68.6 billion by the end of 2028, with a CAGR of 7.5% during the forecast period of 2023-2028.

Report Scope:

This report aims to provide a comprehensive study of the global market for advanced drug delivery systems (ADDS) and processes, both in terms of quantitative and qualitative data, to help people and companies develop business/growth strategies, assess the market landscape, analyze their position in the current marketplace and make informed business decisions about drug deliveries.

This in-depth analysis of the global ADDS market includes historical data and market projections on sales by technology, route of administration, drug vehicles/carriers and application. The analysis describes the different types of ADDS technology (immediate-release drug delivery, extended-release drug delivery, targeted-release drug delivery, delayed-release drug delivery, and pulsatile-release drug delivery) and their current and historical market revenues. It also covers the route of administration of a drug delivery system and the source of a carrier mechanism for drug delivery. In addition, the report examines applications of ADDS (oncology, respiratory, inflammatory and allergies, cardiovascular, ophthalmic, central nervous system, hormone replacement therapy and gynecology, viral and bacterial diseases, diabetes, urology, gastrointestinal disorders, dermatology, other).

The geographic scope of this study covers the U.S. and companies worldwide. The report identifies the main elements of advanced drug delivery products and trends in different industries.

Report Includes:

Table of Contents

Chapter 1 Introduction

Chapter 2 Summary and Highlights

Chapter 3 Market Overview

Chapter 4 Market Dynamics

Chapter 5 Evaluation of the Market Based on Technology

Chapter 6 Evaluation of the Market Based on Route of Administration

Chapter 7 Evaluation of the Market Based on Vehicle/Carrier

Chapter 8 Evaluation of the Market Based on Application

Chapter 9 Evaluation of the Market Based on Geographic Region

Chapter 10 ESG Development

Chapter 11 Emerging Technologies in the Market

Chapter 12 Clinical Trials and Patent Analysis

Chapter 13 Competitive Intelligence

Chapter 14 Company Profiles

Chapter 15 Appendix: Acronyms

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â